In colorectal cancers, the expression of Cyclin G2 is significantly upregulated in macrophages in response to IFN-γ, leading to increased secretion of CXCL9, enhanced CTL chemotaxis, and inhibition of angiogenesis. Here, IFNG is linked to colorectal cancer.